ID

28370

Descrição

The primary objective of the study is to assess the clinical effects of natalizumab versus placebo in acute ischemic stroke on clinical measures of functional independence and activities of daily living. The secondary objective of the study is to explore dose and exposure response and the clinical treatment effects of natalizumab versus placebo in acute ischemic stroke on the following: measures of independence, activities of daily living, neurologic function, quality of life, cognition, and safety and tolerability. https://clinicaltrials.gov/ct2/show/study/NCT02730455.

Link

https://clinicaltrials.gov/ct2/show/study/NCT02730455

Palavras-chave

Versões (1)
  1. 08/01/2018 08/01/2018 -
Titular dos direitos

Biogen

Transferido a

8 de janeiro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility criteria ACTION 2 Acute Ischemic Stroke NCT02730455

Inglês

Eligibility criteria ACTION 2 Acute Ischemic Stroke NCT02730455

1 Formulários  
Key Inclusion Criteria
Descrição

Key Inclusion Criteria

Age 18 to 80 Years
Descrição

Age

Tipo de dados

boolean

Clinical diagnosis of supratentorial acute ischemic stroke defined by LKN ≤24 hours prior to study treatment initiation
Descrição

diagnosis of stroke

Tipo de dados

boolean

Score of 5 to 23 points, inclusive, on the NIHSS at Screening for subjects initiating treatment ≤9 hours from LKN
Descrição

Note: NIHSS eligibility must be confirmed within 60 minutes prior to randomization

Tipo de dados

boolean

Score of 5 to 15 points, inclusive, on the NIHSS at Screening for subjects initiating treatment >9 to ≤24 hours from LKN
Descrição

Note: NIHSS eligibility must be confirmed within 60 minutes prior to randomization

Tipo de dados

boolean

Prior to index stroke, patient was able to perform basic activities of daily living without assistance: dressing, eating, walking, bathing, and using the toilet
Descrição

basic activities of daily living

Tipo de dados

boolean

For those subjects who underwent a cranial MRI, there is at least 1 acute infarct with a diameter of ≥2 cm on baseline brain diffusion-weighted imaging
Descrição

acute infarct diameter MRI

Tipo de dados

boolean

Key Exclusion Criteria
Descrição

Key Exclusion Criteria

Lacunar or isolated brainstem or cerebellar stroke based on clinical assessment and available acute imaging studies performed under the standard of care
Descrição

brainstem or cerebellar stroke

Tipo de dados

boolean

Presence of acute intracranial hemorrhage on acute brain CT or MRI. However, petechial hemorrhages of ≤1 cm are not exclusionary
Descrição

acute intracranial hemorrhage

Tipo de dados

boolean

Severe stroke defined by imaging criteria based on either one of the following: Alberta Stroke Program Early CT (ASPECT) score of 0 to 4 based on head CT or Acute infarct volume on MRI diffusion weighed imaging greater than or equal to 70 mL
Descrição

Severe stroke

Tipo de dados

boolean

Seizure at the onset of stroke
Descrição

Seizure

Tipo de dados

boolean

Known history of prior treatment with natalizumab
Descrição

natalizumab

Tipo de dados

boolean

Known history of active viral hepatitis B or C
Descrição

hepatitis B or C

Tipo de dados

boolean

Signs and symptoms of active or acute infection
Descrição

infection

Tipo de dados

boolean

Voltar ao início da página

Similar models

Eligibility criteria ACTION 2 Acute Ischemic Stroke NCT02730455

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Key Inclusion Criteria
Age
Item
Age 18 to 80 Years
boolean
diagnosis of stroke
Item
Clinical diagnosis of supratentorial acute ischemic stroke defined by LKN ≤24 hours prior to study treatment initiation
boolean
NIHSS score within 9 hours of last known normal
Item
Score of 5 to 23 points, inclusive, on the NIHSS at Screening for subjects initiating treatment ≤9 hours from LKN
boolean
NIHSS score 9-24 hours after last known normal
Item
Score of 5 to 15 points, inclusive, on the NIHSS at Screening for subjects initiating treatment >9 to ≤24 hours from LKN
boolean
basic activities of daily living
Item
Prior to index stroke, patient was able to perform basic activities of daily living without assistance: dressing, eating, walking, bathing, and using the toilet
boolean
acute infarct diameter MRI
Item
For those subjects who underwent a cranial MRI, there is at least 1 acute infarct with a diameter of ≥2 cm on baseline brain diffusion-weighted imaging
boolean
Item Group
Key Exclusion Criteria
brainstem or cerebellar stroke
Item
Lacunar or isolated brainstem or cerebellar stroke based on clinical assessment and available acute imaging studies performed under the standard of care
boolean
acute intracranial hemorrhage
Item
Presence of acute intracranial hemorrhage on acute brain CT or MRI. However, petechial hemorrhages of ≤1 cm are not exclusionary
boolean
Severe stroke
Item
Severe stroke defined by imaging criteria based on either one of the following: Alberta Stroke Program Early CT (ASPECT) score of 0 to 4 based on head CT or Acute infarct volume on MRI diffusion weighed imaging greater than or equal to 70 mL
boolean
Seizure
Item
Seizure at the onset of stroke
boolean
natalizumab
Item
Known history of prior treatment with natalizumab
boolean
hepatitis B or C
Item
Known history of active viral hepatitis B or C
boolean
infection
Item
Signs and symptoms of active or acute infection
boolean
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial